({3-[(2R,3R,4S,5S,6R)-3,4-Diacetoxy-6-acetoxymethyl-5-((2R,3R,4S,5S,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxy]-propylcarbamoyl}-methoxy)-acetic acid | 819053-58-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: ({3-[(2R,3R,4S,5S,6R)-3,4-Diacetoxy-6-acetoxymethyl-5-((2R,3R,4S,5S,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxy]-propylcarbamoyl}-methoxy)-acetic acid
• 英文别名: 2-[2-[3-[(2R,3R,4S,5S,6R)-3,4-diacetyloxy-6-(acetyloxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxan-2-yl]oxypropylamino]-2-oxoethoxy]acetic acid
• CAS: 819053-58-2
• 化学式: C₃₃H₄₇NO₂₂
• 分子量: 809.73
• InChiKey: BJKIXSIVYYZKSY-MDXZBNNRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.6
• 重原子数：
  56
• 可旋转键数：
  27
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  297
• 氢给体数：
  2
• 氢受体数：
  22

反应信息

• 作为反应物：
  描述：

  ({3-[(2R,3R,4S,5S,6R)-3,4-Diacetoxy-6-acetoxymethyl-5-((2R,3R,4S,5S,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxy]-propylcarbamoyl}-methoxy)-acetic acid 在 sodium methylate 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 3-{2-[2-({3-[(2R,3R,4R,5R,6R)-3,4-Dihydroxy-6-hydroxymethyl-5-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxy]-propylcarbamoyl}-methoxy)-acetylamino]-ethoxy}-benzoic acid methyl ester
  参考文献：
  名称：

  Inhibition of Streptococcus suis Adhesion by Dendritic Galabiose Compounds at Low Nanomolar Concentration

  摘要：

  A series of mono-, di-, and tetravalent galablose (Ga1alpha1-4Gal) compounds were synthesized in good yields by coupling of a general carboxylic acid-bearing sugar building block to dendritic scaffolds based on the 3,5-di-(2-aminoethoxy)benzoic acid branching unit. Furthermore. a poly(amidoamine)- (PAMAM-) based dendritic galabioside was Synthesized containing eight galabiose units. All galabiosides were tested in a hemagglutination assay and a Surface plasmon resonance (SPR) competition assay in order to establish their potency in the binding to the bacterial Gram-positive pathogen Streptococcus suis. A monovalent cralabioside containing a short spacer was used as a reference compound in all the assays. Varations in the scaffold as well as in the spacer arms were introduced to determine their influence on the inhibition. The best inhibitor of hemagglutination was an octavalent galabioside with a minimal inhibitory concentration (MIC) of 0.3 nM, to the best of our knowledge the first, example of inhibition of bacterial binding by a soluble carbohydrate at a subnanomolar concentration.

  DOI：

  10.1021/jm049476+
• 作为产物：
  描述：

  3-(N-tert-butyloxycarbonyl)aminopropyl (2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-acetyl-β-D-galactopyranoside 在 吡啶 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 4.0h， 生成 ({3-[(2R,3R,4S,5S,6R)-3,4-Diacetoxy-6-acetoxymethyl-5-((2R,3R,4S,5S,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxy]-propylcarbamoyl}-methoxy)-acetic acid
  参考文献：
  名称：

  Inhibition of Streptococcus suis Adhesion by Dendritic Galabiose Compounds at Low Nanomolar Concentration

  摘要：

  A series of mono-, di-, and tetravalent galablose (Ga1alpha1-4Gal) compounds were synthesized in good yields by coupling of a general carboxylic acid-bearing sugar building block to dendritic scaffolds based on the 3,5-di-(2-aminoethoxy)benzoic acid branching unit. Furthermore. a poly(amidoamine)- (PAMAM-) based dendritic galabioside was Synthesized containing eight galabiose units. All galabiosides were tested in a hemagglutination assay and a Surface plasmon resonance (SPR) competition assay in order to establish their potency in the binding to the bacterial Gram-positive pathogen Streptococcus suis. A monovalent cralabioside containing a short spacer was used as a reference compound in all the assays. Varations in the scaffold as well as in the spacer arms were introduced to determine their influence on the inhibition. The best inhibitor of hemagglutination was an octavalent galabioside with a minimal inhibitory concentration (MIC) of 0.3 nM, to the best of our knowledge the first, example of inhibition of bacterial binding by a soluble carbohydrate at a subnanomolar concentration.

  DOI：

  10.1021/jm049476+